Back
Voyager Therapeutics 10K Form
Sell
40
VYGR
Voyager Therapeutics
Last Price:
7.41
Seasonality Move:
2.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VYGR News And Ratings
See the #1 stock for the next 7 days that we like better than VYGR
VYGR Financial Statistics
Sales & Book Value
| Annual Sales: | $250.01M |
|---|---|
| Cash Flow: | $-24.52M |
| Price / Cash Flow: | 4.6 |
| Annual Sales: | $5.37 |
| Price / Book: | 1.76 |
Profitability
| EPS (TTM): | 3.03000 |
|---|---|
| Net Income (TTM): | $132.33M |
| Gross Margin: | -- |
| Return on Equity: | 74.55% |
| Return on Assets: | 45.41% |
Voyager Therapeutics Earnings Forecast
Key Voyager Therapeutics Financial Ratios
- The Research & Development expenses have been 36.87% of Revenue.
- The Net Earning history of VYGR is 52.93% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 5 years.
Voyager Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VYGR |
| CUSIP: | 92915B |
| Website: | voyagertherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.96 |
| Quick Ratio: | 4.89 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.57 |
|---|---|
| Forward P/E Ratio: | 0 |
VYGR Technical Analysis vs Fundamental Analysis
Sell
40
Voyager Therapeutics (VYGR)
is a Sell
Is Voyager Therapeutics a Buy or a Sell?
-
Voyager Therapeutics stock is rated a Sell
The current Voyager Therapeutics [VYGR] share price is $7.42. The Score for VYGR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.